Copyright Reports & Markets. All rights reserved.

Global Innovative Small Molecule Targeted Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Innovative Small Molecule Targeted Drugs
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Innovative Small Molecule Targeted Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Kinase Inhibitors
    • 1.3.3 Epigenetic Inhibitors
    • 1.3.4 Proteasome Inhibitor
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Innovative Small Molecule Targeted Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Pharmacy
  • 1.5 Global Innovative Small Molecule Targeted Drugs Market Size & Forecast
    • 1.5.1 Global Innovative Small Molecule Targeted Drugs Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Innovative Small Molecule Targeted Drugs Sales Quantity (2018-2029)
    • 1.5.3 Global Innovative Small Molecule Targeted Drugs Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Innovative Small Molecule Targeted Drugs Product and Services
    • 2.1.4 Roche Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Roche Recent Developments/Updates
  • 2.2 Pfizer
    • 2.2.1 Pfizer Details
    • 2.2.2 Pfizer Major Business
    • 2.2.3 Pfizer Innovative Small Molecule Targeted Drugs Product and Services
    • 2.2.4 Pfizer Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Pfizer Recent Developments/Updates
  • 2.3 Genetech
    • 2.3.1 Genetech Details
    • 2.3.2 Genetech Major Business
    • 2.3.3 Genetech Innovative Small Molecule Targeted Drugs Product and Services
    • 2.3.4 Genetech Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Genetech Recent Developments/Updates
  • 2.4 Novartis
    • 2.4.1 Novartis Details
    • 2.4.2 Novartis Major Business
    • 2.4.3 Novartis Innovative Small Molecule Targeted Drugs Product and Services
    • 2.4.4 Novartis Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Novartis Recent Developments/Updates
  • 2.5 Bayer
    • 2.5.1 Bayer Details
    • 2.5.2 Bayer Major Business
    • 2.5.3 Bayer Innovative Small Molecule Targeted Drugs Product and Services
    • 2.5.4 Bayer Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Bayer Recent Developments/Updates
  • 2.6 Abbive
    • 2.6.1 Abbive Details
    • 2.6.2 Abbive Major Business
    • 2.6.3 Abbive Innovative Small Molecule Targeted Drugs Product and Services
    • 2.6.4 Abbive Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Abbive Recent Developments/Updates
  • 2.7 Jiangsu Hengrui Pharmaceuticals
    • 2.7.1 Jiangsu Hengrui Pharmaceuticals Details
    • 2.7.2 Jiangsu Hengrui Pharmaceuticals Major Business
    • 2.7.3 Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Product and Services
    • 2.7.4 Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
  • 2.8 Jiangsu Chia Tai-Tianqing Pharmaceutical
    • 2.8.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Details
    • 2.8.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Major Business
    • 2.8.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Product and Services
    • 2.8.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
  • 2.9 QILU Pharmaceutical
    • 2.9.1 QILU Pharmaceutical Details
    • 2.9.2 QILU Pharmaceutical Major Business
    • 2.9.3 QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Product and Services
    • 2.9.4 QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 QILU Pharmaceutical Recent Developments/Updates
  • 2.10 Betta Pharmaceuticals
    • 2.10.1 Betta Pharmaceuticals Details
    • 2.10.2 Betta Pharmaceuticals Major Business
    • 2.10.3 Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Product and Services
    • 2.10.4 Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Betta Pharmaceuticals Recent Developments/Updates
  • 2.11 Shanghai Junshi Biosciences
    • 2.11.1 Shanghai Junshi Biosciences Details
    • 2.11.2 Shanghai Junshi Biosciences Major Business
    • 2.11.3 Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Product and Services
    • 2.11.4 Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Shanghai Junshi Biosciences Recent Developments/Updates
  • 2.12 Shanghai Allist Pharmaceuticals
    • 2.12.1 Shanghai Allist Pharmaceuticals Details
    • 2.12.2 Shanghai Allist Pharmaceuticals Major Business
    • 2.12.3 Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Product and Services
    • 2.12.4 Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Shanghai Allist Pharmaceuticals Recent Developments/Updates
  • 2.13 Shenzhen Chipscreen Biosciences
    • 2.13.1 Shenzhen Chipscreen Biosciences Details
    • 2.13.2 Shenzhen Chipscreen Biosciences Major Business
    • 2.13.3 Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Product and Services
    • 2.13.4 Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Shenzhen Chipscreen Biosciences Recent Developments/Updates
  • 2.14 Innovent Biologics, Inc.
    • 2.14.1 Innovent Biologics, Inc. Details
    • 2.14.2 Innovent Biologics, Inc. Major Business
    • 2.14.3 Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Product and Services
    • 2.14.4 Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Innovent Biologics, Inc. Recent Developments/Updates
  • 2.15 Hinova Pharmaceuticals
    • 2.15.1 Hinova Pharmaceuticals Details
    • 2.15.2 Hinova Pharmaceuticals Major Business
    • 2.15.3 Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Product and Services
    • 2.15.4 Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Hinova Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Innovative Small Molecule Targeted Drugs by Manufacturer

  • 3.1 Global Innovative Small Molecule Targeted Drugs Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Innovative Small Molecule Targeted Drugs Revenue by Manufacturer (2018-2023)
  • 3.3 Global Innovative Small Molecule Targeted Drugs Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Innovative Small Molecule Targeted Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Innovative Small Molecule Targeted Drugs Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Innovative Small Molecule Targeted Drugs Manufacturer Market Share in 2022
  • 3.5 Innovative Small Molecule Targeted Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Innovative Small Molecule Targeted Drugs Market: Region Footprint
    • 3.5.2 Innovative Small Molecule Targeted Drugs Market: Company Product Type Footprint
    • 3.5.3 Innovative Small Molecule Targeted Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Innovative Small Molecule Targeted Drugs Market Size by Region
    • 4.1.1 Global Innovative Small Molecule Targeted Drugs Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Innovative Small Molecule Targeted Drugs Consumption Value by Region (2018-2029)
    • 4.1.3 Global Innovative Small Molecule Targeted Drugs Average Price by Region (2018-2029)
  • 4.2 North America Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029)
  • 4.3 Europe Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029)
  • 4.5 South America Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2029)
  • 5.2 Global Innovative Small Molecule Targeted Drugs Consumption Value by Type (2018-2029)
  • 5.3 Global Innovative Small Molecule Targeted Drugs Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2029)
  • 6.2 Global Innovative Small Molecule Targeted Drugs Consumption Value by Application (2018-2029)
  • 6.3 Global Innovative Small Molecule Targeted Drugs Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2029)
  • 7.2 North America Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2029)
  • 7.3 North America Innovative Small Molecule Targeted Drugs Market Size by Country
    • 7.3.1 North America Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Innovative Small Molecule Targeted Drugs Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2029)
  • 8.2 Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2029)
  • 8.3 Europe Innovative Small Molecule Targeted Drugs Market Size by Country
    • 8.3.1 Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Innovative Small Molecule Targeted Drugs Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Innovative Small Molecule Targeted Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Innovative Small Molecule Targeted Drugs Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2029)
  • 10.2 South America Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2029)
  • 10.3 South America Innovative Small Molecule Targeted Drugs Market Size by Country
    • 10.3.1 South America Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Innovative Small Molecule Targeted Drugs Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Innovative Small Molecule Targeted Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Innovative Small Molecule Targeted Drugs Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Innovative Small Molecule Targeted Drugs Market Drivers
  • 12.2 Innovative Small Molecule Targeted Drugs Market Restraints
  • 12.3 Innovative Small Molecule Targeted Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Innovative Small Molecule Targeted Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Innovative Small Molecule Targeted Drugs
  • 13.3 Innovative Small Molecule Targeted Drugs Production Process
  • 13.4 Innovative Small Molecule Targeted Drugs Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Innovative Small Molecule Targeted Drugs Typical Distributors
  • 14.3 Innovative Small Molecule Targeted Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Innovative Small Molecule Targeted Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    This report is a detailed and comprehensive analysis for global Innovative Small Molecule Targeted Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Innovative Small Molecule Targeted Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Innovative Small Molecule Targeted Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Innovative Small Molecule Targeted Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Innovative Small Molecule Targeted Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Innovative Small Molecule Targeted Drugs
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Innovative Small Molecule Targeted Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Pfizer, Genetech, Novartis and Bayer, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Innovative Small Molecule Targeted Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Kinase Inhibitors
    Epigenetic Inhibitors
    Proteasome Inhibitor
    Market segment by Application
    Hospital
    Pharmacy
    Major players covered
    Roche
    Pfizer
    Genetech
    Novartis
    Bayer
    Abbive
    Jiangsu Hengrui Pharmaceuticals
    Jiangsu Chia Tai-Tianqing Pharmaceutical
    QILU Pharmaceutical
    Betta Pharmaceuticals
    Shanghai Junshi Biosciences
    Shanghai Allist Pharmaceuticals
    Shenzhen Chipscreen Biosciences
    Innovent Biologics, Inc.
    Hinova Pharmaceuticals
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Innovative Small Molecule Targeted Drugs product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Innovative Small Molecule Targeted Drugs, with price, sales, revenue and global market share of Innovative Small Molecule Targeted Drugs from 2018 to 2023.
    Chapter 3, the Innovative Small Molecule Targeted Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Innovative Small Molecule Targeted Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Innovative Small Molecule Targeted Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Innovative Small Molecule Targeted Drugs.
    Chapter 14 and 15, to describe Innovative Small Molecule Targeted Drugs sales channel, distributors, customers, research findings and conclusion.

    Buy now